Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial-Reference-Cited by-同舟云学术

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

Published:2023-03 Issue:3 Volume:22 Page:209-217
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Lipton Richard B,Croop Robert,Stock David A,Madonia Jennifer,Forshaw Micaela,Lovegren Meghan,Mosher Linda,Coric Vladimir,Goadsby Peter J

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference30 articles.

1. The International Classification of Headache Disorders, 3rd edition;Cephalalgia,2018

2. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Stovner;Lancet Neurol,2018

3. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study;Buse;Headache,2012

4. Interictal burden attributable to episodic headache: findings from the Eurolight project;Lampl;J Headache Pain,2016

5. Real-World experience of interictal burden and treatment in migraine: a qualitative interview study;Lo;J Headache Pain,2022

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity;European Journal of Medicinal Chemistry;2024-12

2. A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects;European Journal of Medicinal Chemistry;2024-10

3. Medication-Overuse Headache: Update on Management;Life;2024-09-11

4. Migraine Treatment: When, Why, and How to Introduce Antimigraine Therapies;The Journal for Nurse Practitioners;2024-09

5. Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics;The Journal of Headache and Pain;2024-08-28